Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 11.60% is 70% above its 5-year average of 6.81%, near the high end of its 5-year range (-16.62%–16.86%).
6.02% below its 12-month average of 12.34%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.86%.
NET PROFIT MARGIN
11.60%
NET PROFIT MARGIN AVG TTM
12.34%
NET PROFIT MARGIN AVG 3Y
9.12%
NET PROFIT MARGIN AVG 5Y
6.81%
NET PROFIT MARGIN AVG 10Y
7.09%
NET PROFIT MARGIN AVG 15Y
2.85%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.02%
CURRENT VS 3Y AVG
+27.22%
CURRENT VS 5Y AVG
+70.29%
CURRENT VS 10Y AVG
+63.63%
CURRENT VS 15Y AVG
+307.73%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$471.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
11.36%
5Y Avg
9.09%
Market Cap
$474.59M
Net Profit Margin
-3.06%
TTM Avg
-9.59%
3Y Avg
-17.39%
5Y Avg
-29.37%
Market Cap
$468.51M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$469.01M
Net Profit Margin
-35.69%
TTM Avg
-57.08%
3Y Avg
-75.90%
5Y Avg
-92.95%
Market Cap
$479.39M
Net Profit Margin
2.94%
TTM Avg
-53.14%
3Y Avg
-197.29%
5Y Avg
-267.69%
Market Cap
$486.60M
Net Profit Margin
11.55%
TTM Avg
13.38%
3Y Avg
8.98%
5Y Avg
-0.37%
Market Cap
$496.23M
Net Profit Margin
-32724.20%
TTM Avg
-6251.97%
3Y Avg
-3125.99%
5Y Avg
-2083.99%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kamada Ltd. (KMDA) | $472.23M | 11.60% | 12.34% | 9.12% | 6.81% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $471.97M | 0.00% | 0.00% | 11.36% | 9.09% |
| Cerus Corporation (CERS)vs › | $474.59M | -3.06% | -9.59% | -17.39% | -29.37% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $468.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sight Sciences, Inc. (SGHT)vs › | $469.01M | -35.69% | -57.08% | -75.90% | -92.95% |
| Arvinas, Inc. (ARVN)vs › | $479.39M | 2.94% | -53.14% | -197.29% | -267.69% |
| NRC Health (NRC)vs › | $460.42M | 4.18% | 12.88% | 16.89% | 20.14% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 11.55% | 13.38% | 8.98% | -0.37% |
| Oculis Holding AG (OCS)vs › | $496.23M | -32724.20% | -6251.97% | -3125.99% | -2083.99% |
| Evolus, Inc. (EOLS)vs › | $495.50M | -10.85% | -18.16% | -29.23% | -75.36% |
Operating Margin
14.5%
Net Profit Margin
11.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 16.86% |
| 2026-03-31 | 9.13% |
| 2025-12-31 | 7.97% |
| 2025-09-30 | 11.27% |
| 2025-06-30 | 16.48% |
| 2025-03-31 | 9.01% |
| 2024-12-31 | 9.76% |
| 2024-09-30 | 9.25% |
| 2024-06-30 | 10.42% |
| 2024-03-31 | 6.27% |
| 2023-12-31 | 13.88% |
| 2023-09-30 | 8.50% |
| 2023-06-30 | 4.84% |
| 2023-03-31 | -5.89% |
| 2022-12-31 | 6.48% |
| 2022-09-30 | 1.50% |
| 2022-06-30 | -16.62% |
| 2022-03-31 | -6.51% |
| 2021-12-31 | -15.92% |
| 2021-09-30 | -3.67% |
| 2021-06-30 | 3.87% |
| 2021-03-31 | 10.79% |
| 2020-12-31 | 5.16% |
| 2020-09-30 | 19.35% |
| 2020-06-30 | 10.45% |
| 2020-03-31 | 15.67% |
| 2019-12-31 | 16.72% |
| 2019-09-30 | 17.61% |
| 2019-06-30 | 17.43% |
| 2019-03-31 | 18.37% |
| 2018-12-31 | 36.81% |
| 2018-09-30 | -15.97% |
| 2018-06-30 | 16.80% |
| 2018-03-31 | 7.20% |
| 2017-12-31 | 17.51% |
| 2017-09-30 | -1.03% |
| 2017-06-30 | 14.94% |
| 2017-03-31 | -34.14% |
| 2016-12-31 | -7.45% |
| 2016-09-30 | -5.37% |
| 2016-06-30 | -8.31% |
| 2016-03-31 | -15.54% |
| 2015-12-31 | 3.82% |
| 2015-09-30 | -28.76% |
| 2015-06-30 | -12.17% |
| 2015-03-31 | -59.28% |
| 2014-12-31 | 6.77% |
| 2014-09-30 | -16.89% |
| 2014-06-30 | -52.93% |
| 2014-03-31 | -23.67% |
| 2013-12-31 | 6.35% |
| 2013-09-30 | 0.21% |
| 2013-06-30 | 5.52% |
| 2013-03-31 | -16.16% |
| 2012-12-31 | 13.21% |
| 2012-09-30 | 0.58% |
| 2012-06-30 | -16.21% |
